Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

Abstract

To assess factors influencing the success of whole genome sequencing for mainstream clinical diagnosis, we sequenced 217 individuals from 156 independent cases across a broad spectrum of disorders in whom prior screening had identified no pathogenic variants. We quantified the number of candidate variants identified using different strategies for variant calling, filtering, annotation and prioritisation. We found that jointly calling variants across samples, filtering against both local and external databases, deploying multiple annotation tools and using familial transmission above biological plausibility contributed to accuracy. Overall, we identified disease causing variants in 21% of cases, rising to 34% (23/68) for Mendelian disorders and 57% (8/14) in trios. We also discovered 32 potentially clinically actionable variants in 18 genes unrelated to the referral disorder, though only four were ultimately considered reportable. Our results demonstrate the value of genome sequencing for routine clinical diagnosis, but also highlight many outstanding challenges.Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use

Loss of function of the retinoid-related nuclear receptor (RORB) gene and epilepsy

“…The BRCA2 frameshift variant (NM_00005) c.9699_9702delTATG (p.Cys3233Trpfs*15), which was found in patients 4, 13, and 20, can be considered an incidental finding. 19 Patients with de novo mutations involving RORB Patient AG1. This girl was the child of unrelated parents.…”

Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature

“…3 Given this, several studies have investigated the benefits arising from the application of WES and WGS in the clinic. These studies have primarily focused on intellectual learning disability 4 or Mendelian conditions more broadly, 3,[5][6][7][8][9] consistently reporting diagnostic yields between 25 and 30%. In addition, WES and WGS have often informed prognoses or treatment of patients, for example in inflammatory bowel disease 10 and epilepsies.…”

Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations

“…We defined a custom-made panel of 21 candidate genes from key pathways involved in the pathogenesis of erythrocytosis, and used it to sequence 125 patients with idiopathic erythrocytosis. We also included novel candidate genes suggested by an initial WGS study, the WGS500 project, 16 in which 500 samples across a diverse spectrum of clinical disorders were sequenced, including some cases of idiopathic erythrocytosis strongly suspected of having a genetic cause.…”